| B20 | Cancer among people living with HIV in Ontario, Canada: a population-based matched cohort study among individuals with and without HIV | E-poster | Malignancies (AIDS and non-AIDS related) |
| B20 | Efficacy and safety of topical trichloroacetic acid vs. electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive patients (TECAIN): a randomized controlled trial | E-poster | Malignancies (AIDS and non-AIDS related) |
| B21 | Smoking and binge alcohol use are associated with incident venous thromboembolism in an HIV cohort | E-poster | Cardiovascular disease |
| B21 | The association of coronary calcification with visceral adiposity in people living with HIV. Results from the Liverpool multiparametric imaging collaboration | E-poster | Cardiovascular disease |
| B21 | Virological suppression in people living with HIV infection is not protective of subclinical atherosclerosis | E-poster | Cardiovascular disease |
| B21 | Prediction of coronary artery disease in high-risk people living with HIV in Asia | E-poster | Cardiovascular disease |
| B23 | Ageing and renal insufficiency in persons living with and without HIV in AFRICOS | E-poster | Renal disease |
| B24 | Impact of COVID-19-related lockdown on the metabolic profile of people living with HIV in Argentina | E-poster | Metabolic, lipid and endocrine complications (including obesity, hyperlipidaemia and lipodystrophy) |
| B24 | Dolutegravir-based regimen is associated with metabolic syndrome components among persons with HIV in sub-Saharan Africa | E-poster | Metabolic, lipid and endocrine complications (including obesity, hyperlipidaemia and lipodystrophy) |
| B24 | Weight gain following the single substitution of TDF by TAF in people living with HIV (PLWH) in the French Dat'AIDS cohort | E-poster | Metabolic, lipid and endocrine complications (including obesity, hyperlipidaemia and lipodystrophy) |